|Title:||The Hepatitis Viral Status in Patients with Hepatocellular Carcinoma: A Study of 3843 Patients from Taiwan Liver Cancer Network||Authors:||Chang I.-C.
|Issue Date:||2016||Publisher:||Lippincott Williams and Wilkins||Journal Volume:||95||Journal Issue:||15||Start page/Pages:||e3284||Source:||Medicine (United States)||Abstract:||
Hepatocellular carcinoma (HCC) is the leading cancer death in Taiwan. Chronic viral hepatitis infections have long been considered as the most important risk factors for HCC in Taiwan. The previously published reports were either carried out by individual investigators with small patient numbers or by large endemic studies with limited viral marker data. Through collaboration with 5 medical centers across Taiwan, Taiwan liver cancer network (TLCN) was established in 2005. All participating centers followed a standard protocol to recruit liver cancer patients along with their biosamples and clinical data. In addition, detailed viral marker analysis for hepatitis B virus (HBV) and hepatitis C virus (HCV) were also performed. This study included 3843 HCC patients with available blood samples in TLCN (recruited from November 2005 to April 2011). There were 2153 (56.02%) patients associated with HBV (HBV group); 969 (25.21%) with HCV (HCV group); 310 (8.07%) with both HBV and HCV (HBV+HCV group); and 411 (10.69%) were negative for both HBV and HCV (non-B non-C group). Two hundred two of the 2463 HBV patients (8.20%) were HBsAg(-), but HBV DNA (+). The age, gender, cirrhosis, viral titers, and viral genotypes were all significantly different between the above 4 groups of patients. The median age of the HBV group was the youngest, and the cirrhotic rate was lowest in the non-B non-C group (only 25%). This is the largest detailed viral hepatitis marker study for HCC patients in the English literatures. Our study provided novel data on the interaction of HBV and HCV in the HCC patients and also confirmed that the HCC database of TLCN is highly representative for Taiwan and an important resource for HCC research. ? 2016 Wolters Kluwer Health, Inc. All rights reserved.
|ISSN:||0025-7974||DOI:||10.1097/MD.0000000000003284||SDG/Keyword:||hepatitis B surface antigen; virus DNA; virus RNA; hepatitis B surface antigen; virus DNA; adult; aged; Article; blood sampling; cancer research; clinical feature; female; genotype; health care organization; Hepatitis B virus; Hepatitis C virus; human; liver cell carcinoma; liver cirrhosis; major clinical study; male; priority journal; risk factor; Taiwan; very elderly; virus gene; virus hepatitis; age; Carcinoma, Hepatocellular; genetics; Hepacivirus; hepatitis B; Hepatitis B virus; hepatitis C; immunology; information processing; isolation and purification; liver cirrhosis; Liver Neoplasms; middle aged; pathology; sex difference; virology; Adult; Age Factors; Aged; Carcinoma, Hepatocellular; Data Collection; DNA, Viral; Female; Hepacivirus; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis C; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Risk Factors; Sex Factors; Taiwan
|Appears in Collections:||醫學系|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.